Commentary on Copeland et al.: Does xylazine in the United Kingdom foreshadow a European synthetic polysubstance drug crisis?

Documents similaires

• Commentary on Pardo et al.: Whatever the past situation, drug precursor chemicals may in future represent an important source for synthetic drug production in Afghanistan and surrounding countries
  par: Alexander Soderholm, et autres
  Publié: (2024)
• Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug‐testing and law enforcement
  par: Caroline S. Copeland, et autres
  Publié: (2024)
• Commentary on ter Laak et al .: The importance of drug market information and differentiating drug use patterns
  par: Rory Verhagen, et autres
  Publié: (2024)
• Commentary on Nieto et al .: The heterogeneity of drug craving and considerations as a treatment endpoint
  par: Justin C. Strickland, et autres
  Publié: (2026)
• Transitions to polysubstance use: Prospective cohort study of adolescents in Australia
  par: Nicola Black, et autres
  Publié: (2024)